fashion -WSS

fashion

author：comprehensive 2025-08-19 12:10:17 - browse：728

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

WSS

Pregnancy ages women, but effects reverse after delivery

Surgeons perform first xenotransplant using CRISPR'd pig kidney

A solution to the after

'Patient friction coefficient' can gauge a clinical trial's patient burden

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Readout Newsletter: Illumina, CRISPR, Regeneron

focus

fashion

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Asbestos ban is immediate, but health effects will linger for decades

Trump demands the U.S. pay no more for drugs than other countries … again

Texas board proposes rules on abortion law emergency exemption

Virginia high school admissions case could be legal follow

Cancer, immunology, HIV research ensnared in fetal tissue politics

Supreme Court strikes down use of affirmative action

Pfizer, Moderna say biotech, pharma drug development is a sprint

How one medical school became remarkably diverse

With competition flaring, obesity drug hits goal in liver disease study

hotspot

A solution to the after

Alabama frozen embryo ruling has major implications for IVF clinics

Alabama hospital puts IVF treatments on hold

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

6 phony surgeries that take placebo to the extreme

This gene therapy has record $4.25 million price. It's saved children.

explore

explore

entertainment

hotspot